SCHEMBL1062003

SCHEMBL1062003

O=C(O)OC1CCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6843137 1.00
SCHEMBL6383591 1.00
Cadaverine Tartrate SCHEMBL6383184 0.87 TSHR (0.42)
SCHEMBL992914 0.82
SCHEMBL1847352 0.82
SCHEMBL4022578 0.80
SCHEMBL8087363 0.80
SCHEMBL2338824 0.80 MEN1 (0.38)
SCHEMBL11898034 0.80 MEN1 (0.38)
SCHEMBL1981986 0.80 MEN1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3145943-B1 PEPTIDES, COMPOSITIONS COMPRISING THEM AND USES IN PARTICULAR COSMETIC USES SEDERMA SA (FR) 2024-03-13 EP claimed
EP-2922864-B1 PRO-PIGMENTING PEPTIDES SEDERMA SA (FR) 2023-01-04 EP claimed
EP-3645720-B1 METHODS OF CELL SELECTION AND MODIFYING CELL METABOLISM LONZA AG (CH) 2021-03-10 EP claimed
EP-2207876-B1 STEREO-SPECIFIC HYDROXYLATION UNIV BONN (DE) 2015-08-26 EP claimed
EP-1863766-B1 CERTAIN SUBSTITUTED AMIDES, METHOD OF MAKING, AND METHOD OF USE THEREOF GILEAD CONNECTICUT INC (US) 2015-05-20 EP claimed
EP-1937710-B1 KININ B1 RECEPTOR PEPTIDE AGONISTS AND USES THEREOF SOCPRA SCIENCES SANTE ET HUMAINES S E C (CA) 2012-10-17 EP claimed
EP-2207876-A1 STEREO-SPECIFIC HYDROXYLATION Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2010-07-21 EP claimed
WO-2009059783-A1 STEREO-SPECIFIC HYDROXYLATION Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2009-05-14 WO claimed
US-20080161232-A1 C5a is a cleavage product of the complement cascade, the CS convertase; antiinflammatory agents; autoimmune diseases; cyclic peptide compounds JERINI AG (DE) 2008-07-03 US claimed
EP-1193253-B1 PROCESS FOR PRODUCING OPTICALLY ACTIVE AZETIDINE-2-CARBOXYLIC ACIDS KANEKA CORP (JP) 2008-06-25 EP claimed
EP-0804463-A1 NEUROKININE (TACHYKININE) ANTAGONISTS BOEHRINGER INGELHEIM KG (DE) 1997-11-05 EP claimed
EP-0802922-A1 NOVEL AMINO ACID DERIVATIVES, METHOD OF PRODUCING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS BOEHRINGER INGELHEIM KG (DE) 1997-10-29 EP claimed
WO-1995030687-A1 NEUROKININE (TACHYKININE) ANTAGONISTS BOEHRINGER INGELHEIM KG (DE) 1995-11-16 WO claimed
WO-1995023810-A1 NOVEL AMINO ACID DERIVATIVES, METHOD OF PRODUCING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS BOEHRINGER INGELHEIM KG (DE) 1995-09-08 WO claimed
EP-0394989-B1 Peptide compounds, process for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1994-12-21 EP claimed
EP-0393934-B1 Novel peptides, and antidementia agents containing the same NIPPON CHEMIPHAR CO (JP) 1994-11-02 EP claimed
EP-0610487-A1 NEW AMINOACID DERIVATES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS BOEHRINGER INGELHEIM KG (DE) 1994-08-17 EP claimed
WO-1994005693-A1 NEW AMINOACID DERIVATES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS BOEHRINGER INGELHEIM KG (DE) 1994-03-17 WO claimed
EP-0118280-B1 ENZYME INHIBITION Aktiebolaget Hässle (SE) 1989-07-12 EP claimed
EP-0078191-B1 COLLAGEN INHIBITING COMPOSITIONS AND PROCESSES FOR MANUFACTURING AND USING THE SAME UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 1986-09-03 EP claimed